Molecular Imaging

PSMA-PET may require selective use to be cost-effective

By Will Morton

Yale University researcher developed a decision-analytic model to estimate lifetime cost outcomes associated with PSMA-PET.

October 24, 2025

Telix's Zircaix included in society guidelines for renal imaging

By AuntMinnie.com staff writers

Telix welcomes updated guidelines from medical societies for including TLX250-CDx (Zircaix) for imaging renal masses.

October 23, 2025

Andrew Trout tapped to lead radiology at Cincinnati Children's

By AuntMinnie.com staff writers

Trout served as director of nuclear medicine at Cincinnati Children’s from 2016 through 2024.

October 17, 2025

PET/CT reveals ‘chemo brain’ regions in leukemia patients

By Will Morton

Chemotherapy is associated with brain metabolic alterations, particularly in areas governing cognition and emotion.

October 16, 2025

Clarity, Nusano ink Cu-67 supply agreement

By AuntMinnie.com staff writers

Copper-67 (Cu-67) will be produced at Nusano's Utah-based production facility, which will open in late 2025.

October 16, 2025

Nusano, Ariceum Therapeutics sign multi-isotope supply agreement

By AuntMinnie.com staff writers

The agreement will give Ariceum access to Nusano-produced radioisotopes for its novel radiotherapeutics.

October 14, 2025

PSMA-PET/CT reporting varies widely in the U.S.

By Will Morton

Standardized interpretation frameworks for PSMA-PET/CT reporting are underused in the U.S.

October 14, 2025

PET/CT shows value in patients with soft-tissue sarcomas

By Will Morton

PET/CT scans can help identify which patients are most likely to benefit from treatment.

October 13, 2025

SNMMI updates radioisotope production status in U.S.

By AuntMinnie.com staff writers

Projects noted in an October 10 update include IAEA's disused radium transfer program and others.

October 10, 2025

PSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancer

By Will Morton

Replacing F-18 sodium fluoride (NaF) PET/CT with F-18 PSMA PET/CT can improve treatment for men with newly diagnosed prostate cancer.

October 10, 2025

GLP-1 drugs may confound PET/CT imaging findings

By AuntMinnie.com staff writers

The drugs are now widely prescribed for people with type 2 diabetes -- with a 700% use increase in the U.S. between 2019 and 2023.

October 7, 2025

PSMA PET-guided radiotherapy shows promise

By Will Morton

A trial demonstrated that radiotherapy informed by PSMA-PET led to improved outcomes in prostate cancer patients.

October 3, 2025

Page 1 of 616

Next Page